These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 2864375)

  • 1. Mouse skin graft prolongation with donor strain bone marrow and anti-lymphocyte serum: surface markers of the active bone marrow cells.
    De Fazio S; Hartner WC; Monaco AP; Gozzo JJ
    J Immunol; 1985 Nov; 135(5):3034-8. PubMed ID: 2864375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of spleen cells capable of inducing unresponsiveness in ALS-treated mice.
    Wood ML; Monaco AP; Gottschalk R
    Transplantation; 1991 Jan; 51(1):208-13. PubMed ID: 1670969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Murine lymphokine-activated killer (LAK) cells: phenotypic characterization of the precursor and effector cells.
    Yang JC; Mulé JJ; Rosenberg SA
    J Immunol; 1986 Jul; 137(2):715-22. PubMed ID: 2873187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional characteristics of a Ficoll-separated mouse bone marrow cell population involved in skin allograft prolongation.
    Gozzo JJ; Crowley M; Maki T; Monaco AP
    J Immunol; 1982 Oct; 129(4):1584-8. PubMed ID: 6213717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Specific unresponsiveness to skin allografts in anti-lymphocyte serum-treated, marrow-injected mice: participation of donor marrow-derived suppressor T cells.
    Maki T; Gottschalk R; Wood ML; Monaco AP
    J Immunol; 1981 Oct; 127(4):1433-8. PubMed ID: 6168692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antilymphocytic antibodies and marrow transplantation. VII. Two of nine monoclonal anti-Thy-1 antibodies used for pretreatment of donor marrow suppressed graft-versus-host reactions without added complement.
    Thierfelder S; Cobbold S; Kummer U; Waldmann H; Schuh R
    Exp Hematol; 1985 Oct; 13(9):948-55. PubMed ID: 2864278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of selective T cell depletion of host and/or donor bone marrow on lymphopoietic repopulation, tolerance, and graft-vs-host disease in mixed allogeneic chimeras (B10 + B10.D2----B10).
    Ildstad ST; Wren SM; Bluestone JA; Barbieri SA; Stephany D; Sachs DH
    J Immunol; 1986 Jan; 136(1):28-33. PubMed ID: 2933464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of bone marrow allograft rejection and hybrid resistance in nonresponder recipients by antibody: is there evidence for a dual receptor interaction in acute marrow graft rejection?
    Dennert G; Anderson CG; Warner J
    J Immunol; 1986 Jun; 136(11):3981-6. PubMed ID: 3517162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human antibody-dependent cellular cytotoxicity. Isolation and identification of a subpopulation of peripheral blood lymphocytes which kill antibody-coated autologous target cells.
    Brier AM; Chess L; Schlossman SF
    J Clin Invest; 1975 Dec; 56(6):1580-6. PubMed ID: 53242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of cyclophosphamide on the splecific unresponsiveness to skin allografts induced in ALS-treated mice infused with donor bone marrow.
    Wood ML; Monaco AP
    J Immunol; 1977 Apr; 118(4):1456-9. PubMed ID: 321691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surface antigens of the murine cytostatic peritoneal macrophage.
    Hogg N; Parish CR
    Immunology; 1980 Sep; 41(1):187-93. PubMed ID: 6933136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of posttransplant injection of peripheral blood lymphocytes on skin graft prolongation in mice treated with antilymphocyte serum (ALS) or ALS plus donor bone marrow.
    Gozzo JJ; Hartner WC; Monaco AP; De Fazio SR
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1409-10. PubMed ID: 3274341
    [No Abstract]   [Full Text] [Related]  

  • 13. Induction of tolerance to skin allografts by intrathymic injection of donor splenocytes. Effect of donor-recipient strain combination and supplemental rapamycin.
    Dono K; Maki T; Wood ML; Monaco AP
    Transplantation; 1995 Dec; 60(11):1268-73. PubMed ID: 8525521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natural cytotoxicity against mouse hepatitis virus-infected cells. II. A cytotoxic effector cell with a B lymphocyte phenotype.
    Welsh RM; Haspel MV; Parker DC; Holmes KV
    J Immunol; 1986 Feb; 136(4):1454-60. PubMed ID: 3003199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of posttransplantation administration of peripheral blood lymphocytes in skin-grafted mice treated with antilymphocyte serum or antilymphocyte serum plus bone marrow.
    De Fazio SR; Hartner WC; Monaco AP; Gozzo JJ
    Transplantation; 1987 Jul; 44(1):70-5. PubMed ID: 3299924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Donor antigen-presenting cells regulate T-cell expansion and antitumor activity after allogeneic bone marrow transplantation.
    Li JM; Waller EK
    Biol Blood Marrow Transplant; 2004 Aug; 10(8):540-51. PubMed ID: 15282532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apoptotic donor leukocytes limit mixed-chimerism induced by CD40-CD154 blockade in allogeneic bone marrow transplantation.
    Li JM; Gorechlad J; Larsen CP; Waller EK
    Biol Blood Marrow Transplant; 2006 Dec; 12(12):1239-49. PubMed ID: 17162205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abrogation of bone marrow allograft resistance in mice by increased total body irradiation correlates with eradication of host clonable T cells and alloreactive cytotoxic precursors.
    Schwartz E; Lapidot T; Gozes D; Singer TS; Reisner Y
    J Immunol; 1987 Jan; 138(2):460-5. PubMed ID: 3098843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fractionated bone marrow: use of a lymphocyte containing fraction for skin allograft prolongation in antilymphocyte serum (ALS) treated mice.
    Gozzo JJ; Litvin DA; Bhatnagar YM; Monaco AP
    Transplant Proc; 1981 Mar; 13(1 Pt 1):592-5. PubMed ID: 7022895
    [No Abstract]   [Full Text] [Related]  

  • 20. Superiority of sirolimus (rapamycin) over cyclosporine in augmenting allograft and xenograft survival in mice treated with antilymphocyte serum and donor-specific bone marrow.
    Hale DA; Gottschalk R; Fukuzaki T; Wood ML; Maki T; Monaco AP
    Transplantation; 1997 Feb; 63(3):359-64. PubMed ID: 9039923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.